Treximet and Breastfeeding
Clinical studies on Treximet and breastfeeding show that both components of the medication (naproxen and sumatriptan) pass through breast milk in humans. However, these amounts are probably too low to cause serious problems. Before taking Treximet, breastfeeding women should talk to their healthcare providers about any potential risks.
Treximet™ (sumatriptan/naproxen sodium) is a prescription medication approved to treat migraines. Both of the medications in Treximet are known to pass through breast milk in humans. The manufacturer of Treximet recommends that breastfeeding women avoid taking Treximet. Therefore, make sure to check with your healthcare provider before taking Treximet if you are breastfeeding.
Studies have shown that both sumatriptan and naproxen pass through breast milk in humans. However, the amount of these medications that passes through breast milk is so low that serious problems are not expected.
You should talk with your healthcare provider about Treximet and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Treximet and breastfeeding that is right for you.